Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516166 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Triple' returned 3609 results - Page 1 of 181

  Sort by   
  Sorted by Rank Top-Bottom

Triple-Play Forecasts  
Digital TV Research, July 2011, Pages: 153
Triple-Play Forecasts More than a quarter of the world's TV households will subscribe to triple-play services (3P - TV, broadband and telephony) by 2016, according to Digital TV Research. The Triple


Triple Analysis: Leukemia, Lymphoma and Melanoma  
Bioseeker, May 2011, Pages: 2878
Triple Analysis: Leukemia, Lymphoma and Melanoma This triple analysis focuses on cancer drug development strategies in Leukemia, Lymphoma and Melanoma. Each of these three individual parts


Triple Analysis: Leukemia, Lymphoma and Angiogenesis  
Bioseeker, Jan 2012, Pages: 3805
Triple Analysis: Leukemia, Lymphoma and Angiogenesis This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect


Triple Analysis: Leukemia, Lymphoma and Peptides  
Bioseeker, Nov 2011, Pages: 3007
Triple Analysis: Leukemia, Lymphoma and Peptides This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the compound strategy of Peptides. Each


Triple Analysis: Leukemia, Melanoma and Apoptosis  
Bioseeker, Dec 2011, Pages: 3541
Triple Analysis: Leukemia, Melanoma and Apoptosis This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Apoptosis


Triple Analysis: Leukemia, Melanoma and Peptides  
Bioseeker, Nov 2011, Pages: 2830
Triple Analysis: Leukemia, Melanoma and Peptides This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each


Triple Analysis: Leukemia, Angiogenesis and Peptides  
Bioseeker, Jan 2012, Pages: 3757
Triple Analysis: Leukemia, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area


Triple Analysis: Leukemia, Antibodies and Peptides  
Bioseeker, Nov 2011, Pages: 3997
Triple Analysis: Leukemia, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Leukemia and by the two compound strategies of Antibodies and Peptides. Each


Triple Analysis: Lymphoma, Melanoma and Angiogenesis  
Bioseeker, Jan 2012, Pages: 3435
Triple Analysis: Lymphoma, Melanoma and Angiogenesis This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect


Triple Analysis: Lymphoma, Melanoma and Antibodies  
Bioseeker, Sep 2011, Pages: 3675
Triple Analysis: Lymphoma, Melanoma and Antibodies This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Antibodies. Each


Triple Analysis: Lymphoma, Melanoma and Peptides  
Bioseeker, Nov 2011, Pages: 2637
Triple Analysis: Lymphoma, Melanoma and Peptides This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Peptides. Each


Triple Analysis: Lymphoma, Angiogenesis and Antibodies  
Bioseeker, Jan 2012, Pages: 4602
Triple Analysis: Lymphoma, Angiogenesis and Antibodies This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect


Triple Analysis: Lymphoma, Angiogenesis and Peptides  
Bioseeker, Jan 2012, Pages: 3564
Triple Analysis: Lymphoma, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area


Triple Analysis: Lymphoma, Antibodies and Peptides  
Bioseeker, Nov 2011, Pages: 3804
Triple Analysis: Lymphoma, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two compound strategies of Antibodies and Peptides. Each


Triple Analysis: Melanoma, Angiogenesis and Antibodies  
Bioseeker, Jan 2012, Pages: 4425
Triple Analysis: Melanoma, Angiogenesis and Antibodies This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect


Triple Analysis: Melanoma, Angiogenesis and Peptides  
Bioseeker, Jan 2012, Pages: 3387
Triple Analysis: Melanoma, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area


Triple Analysis: Melanoma, Antibodies and Peptides  
Bioseeker, Nov 2011, Pages: 3627
Triple Analysis: Melanoma, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Melanoma and by the two compound strategies of Antibodies and Peptides. Each


Triple Analysis: Angiogenesis, Antibodies and Peptides  
Bioseeker, Jan 2012, Pages: 4554
Triple Analysis: Angiogenesis, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Angiogenesis and by the two compound


Global Triple Play and Next-generation Services Test and Monitoring  
Frost & Sullivan, Dec 2011, Pages: 90
Global Triple Play and Next-generation Services Test and Monitoring World Integrated Triple Play Test and Monitoring Equipment Market to Grow from $187.7 million in 2010 to $487.4 million by 2015


Hygiene and the Triple Bottom Line  
Euromonitor International, Jan 2012, Pages: 41
Hygiene and the Triple Bottom Line Although green products constitute only a small share of even the most developed hygiene markets, environmental issues now permeate from raw material extraction


Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds